ATAZANAVIR KRKA 300 mg, gélule — 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité de 30 gélule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930182185 -
CIP7
3018218 -
CIS
66089188 -
Registration number
EU/1/19/1353
What the source publishes
- Holder
- KRKA (SLOVENIE)
- Active ingredients
- ATAZANAVIR, SULFATE D'ATAZANAVIR
- Form
- gélule
- Package
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité de 30 gélule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription initiale hospitalière annuelle ; liste I
- Marketing status
- Arrêt de commercialisation (le médicament n'a plus d'autorisation)
- Authorised on
- 2019-03-25
- Prescription
- Prescription or restricted
Names this record is found by
- ATAZANAVIR KRKA 300 mg, gélule — 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité de 30 gélule(s)
- ATAZANAVIR KRKA 300 mg, gélule
- ATAZANAVIR
- SULFATE D'ATAZANAVIR
Complete source data
{
"cis": "66089188",
"cip7": "3018218",
"form": "gélule",
"name": "ATAZANAVIR KRKA 300 mg, gélule — 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité de 30 gélule(s)",
"cip13": "3400930182185",
"holder": "KRKA (SLOVENIE)",
"routes": [
"orale"
],
"holders": [
"KRKA (SLOVENIE)"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "161.24",
"authorisedOn": "2019-03-25",
"compositions": [
{
"name": "ATAZANAVIR",
"nature": "FT",
"strength": "300 mg",
"linkageNumber": "1",
"substanceCode": "27570",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
},
{
"name": "SULFATE D'ATAZANAVIR",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "87658",
"dosageReference": null,
"pharmaceuticalElement": "gélule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription initiale hospitalière annuelle ; liste I",
"dispensingFee": "1.02",
"medicinePrice": "160.22",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ATAZANAVIR KRKA 300 mg, gélule",
"marketingStatus": "Arrêt de commercialisation (le médicament n'a plus d'autorisation)",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité de 30 gélule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100 %"
],
"marketingDeclaredOn": "2026-02-23",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ATAZANAVIR",
"SULFATE D'ATAZANAVIR"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription initiale hospitalière annuelle",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/19/1353",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930182185"